RDY240719C70000
- 2.40
- 0.000.00%
Dr Reddy's Laboratories Ltd Newsroom
Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
Asian equities traded in the US as American depositary receipts were trading lower Friday morning, declining 0.46% to 2,010.90 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by we
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Asian equities traded in the US as American depositary receipts were higher in Wednesday trading, rising 1.04% to 2,008.61 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by live g
Asian Equities Traded in the US as American Depositary Receipts Open Week on Flat Note
Asian equities traded in the US as American depositary receipts started the week flat Monday morning, nudging 0.005% higher to 1,959.42 on the S&P Asia 50 ADR Index. From North Asia, the gainers were
Dr. Reddy's to Co-market Zydus' Breast Cancer Treatment in India
Dr. Reddy's Laboratories (RDY) plans to co-market Zydus Lifesciences' Pertuzumab biosimilar to treat breast cancer patients in India. Zydus will market the product under the Sigrima brand name while D
Dr. Reddy's Laboratories Shares Are Trading Higher After the Company Announced It Signed a Definitive Agreement With Haleon for Purchase of Shares of Northstar Switzerland SARL to Acquire Its Global Portfolio of Consumer Healthcare Brands in the...
Dr. Reddy's Laboratories Shares Are Trading Higher After the Company Announced It Signed a Definitive Agreement With Haleon for Purchase of Shares of Northstar Switzerland SARL to Acquire Its Global P
Asian Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
Asian equities traded in the US as American depositary receipts were flat in late Thursday morning trading, nudging 0.04% higher to 1,957.15 on the S&P Asia 50 ADR Index. From North Asia, the gainers
Dr. Reddy's to Acquire Haleon's Nicotine Replacement Therapy Business Outside US
Dr. Reddy's Laboratories (NSE:DRREDDY, BOM:500124), through its Swiss arm, agreed to acquire British consumer healthcare company Haleon's nicotine replacement therapy business outside the US, accordin
Haleon to Sell Overseas Nicotine Therapy Business to Dr. Reddy's
Haleon to Sell Nicotine-Quitting Aid Business for $634 Million
By David Sachs Haleon will sell a significant portion of its nicotine-quitting aid business to Dr. Reddy's Laboratories, an India-based pharmaceutical company, in a 500 million-pound ($634.2 million)
Haleon: All Other 2024 Guidance Unchanged
Haleon: All Other 2024 Guidance Unchanged
Haleon: Sale Will Dilute 2024 Rev by 0.5%, Adj Oper Pft by 1%
Haleon: Sale Will Dilute 2024 Rev by 0.5%, Adj Oper Pft by 1%
Dr. Reddy's Laboratories Switzerland Acquires Haleon Group's Nicotine Replacement Therapy Brands Outside US for GBP 458M, Plus Up to GBP 42M in Contingent Payments in CY 2025 and CY 2026
Dr. Reddy's Laboratories Switzerland Acquires Haleon Group's Nicotine Replacement Therapy Brands Outside US for GBP 458M, Plus Up to GBP 42M in Contingent Payments in CY 2025 and CY 2026
Haleon: Sales Allow For NRT Exit Outside US, Trim Business Complexity
Haleon: Sales Allow For NRT Exit Outside US, Trim Business Complexity
Haleon: Deal Expected to Complete Early 4Q
Haleon: Deal Expected to Complete Early 4Q
Haleon: Use of Proceeds Will in Line With Capital Allocation Priorities
Haleon: Use of Proceeds Will in Line With Capital Allocation Priorities
Haleon: Deal Structure Upfront Cash GBP458M, GBP42M Performance-Based Payable
Haleon: Deal Structure Upfront Cash GBP458M, GBP42M Performance-Based Payable
Haleon: Portfolio Include Nicotinell, Nicabate, Habitrol and Thrive Available in Gum, Lozenge
Haleon: Portfolio Include Nicotinell, Nicabate, Habitrol and Thrive Available in Gum, Lozenge
Haleon: Deal Worth GBP500M With Additional Proceeds From Inventory Transfer
Haleon: Deal Worth GBP500M With Additional Proceeds From Inventory Transfer
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading
Asian equities traded in the US as American depositary receipts were trending sharply higher Tuesday morning, rising 1% to 1,952.84 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led
Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
Asian equities traded in the US as American depositary receipt rose Monday morning with the S&P Asia 50 ADR Index gaining 0.59% to 1,939.47. From North Asia, the gainers were led by internet and data